Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) EBITDA Margin: 2020-2025

Historic EBITDA Margin for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to 15.88%.

  • Cellebrite DI's EBITDA Margin fell 17871.00% to 15.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.19%, marking a year-over-year decrease of 6508.00%. This contributed to the annual value of 70.28% for FY2024, which is 4556.00% up from last year.
  • Latest data reveals that Cellebrite DI reported EBITDA Margin of 15.88% as of Q3 2025, which was down 15.27% from 18.74% recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's EBITDA Margin registered a high of 194.58% during Q3 2024, and its lowest value of 3.12% during Q1 2022.
  • For the 3-year period, Cellebrite DI's EBITDA Margin averaged around 44.72%, with its median value being 19.20% (2024).
  • Per our database at Business Quant, Cellebrite DI's EBITDA Margin surged by 18,582bps in 2024 and then plummeted by 17,871bps in 2025.
  • Over the past 5 years, Cellebrite DI's EBITDA Margin (Quarterly) stood at 6.34% in 2021, then surged by 471bps to 11.06% in 2022, then surged by 398bps to 15.04% in 2023, then soared by 416bps to 19.20% in 2024, then crashed by 17,871bps to 15.88% in 2025.
  • Its last three reported values are 15.88% in Q3 2025, 18.74% for Q2 2025, and 15.07% during Q1 2025.